Dr Reddy#39;s gets the nod to conduct human trials for the vaccine while Mankind Pharma signs an agreement with RIDF that will make 300 million doses of Sputnik V available in India. Post navigation Higher NPAs hinder monetary policy transmission: RBI 6 of top-10 most valued firms#39; combined market valuation tumble over Rs 1 lakh crore